Cangrelor Use in Cardiogenic Shock: A Single-Center Real-World Experience

JACC Cardiovasc Interv. 2017 Aug 28;10(16):1712-1714. doi: 10.1016/j.jcin.2017.07.009.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Humans
  • Shock, Cardiogenic*
  • Stents*
  • Treatment Outcome

Substances

  • Adenosine Monophosphate
  • cangrelor